Lactate dehydrogenase (LDH) is used in dermatology practice, particularly as a prognostic marker for cutaneous lymphoma. LDH is an intracellular enzyme involved in anaerobic glycolysis, and is found at low concentrations in the blood. LDH is produced in every tissue, thus cell damage releases LDH into the circulation, so the causes of elevated LDH levels are multiple. The utility of LDH in dermatology practice is reviewed, alongside current diagnostic and staging guidelines.
CITATION STYLE
Livesey, A., Garty, F., Shipman, A. R., & Shipman, K. E. (2020, July 1). Lactate dehydrogenase in dermatology practice. Clinical and Experimental Dermatology. Blackwell Publishing Ltd. https://doi.org/10.1111/ced.14134
Mendeley helps you to discover research relevant for your work.